IronBridge Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-323,748
Closed -$4.83M 190
2016
Q4
$4.83M Sell
323,748
-160,452
-33% -$2.84M 0.22% 116
2016
Q3
$10.6M Sell
484,200
-37,312
-7% -$830K 0.49% 61
2016
Q2
$10.3M Sell
521,512
-323,340
-38% -$5.51M 0.45% 69
2016
Q1
$14.3M Sell
844,852
-37,040
-4% -$619K 0.58% 57
2015
Q4
$18.1M Buy
881,892
+45,360
+5% +$944K 0.71% 50
2015
Q3
$18M Buy
836,532
+24,916
+3% +$556K 0.7% 46
2015
Q2
$16.2M Sell
811,616
-80,320
-9% -$1.41M 0.49% 63
2015
Q1
$13.9M Sell
891,936
-505,320
-36% -$7.63M 0.4% 68
2014
Q4
$19.2M Buy
1,397,256
+235,160
+20% +$2.88M 0.54% 56
2014
Q3
$11.6M Sell
1,162,096
-33,700
-3% -$344K 0.31% 88
2014
Q2
$11.9M Buy
+1,195,796
New +$10.6M 0.29% 96

Other funds holding DXCM

IronBridge Capital Management's DXCM Position: Q1 2017 in Review

IronBridge Capital Management sold out of DexCom (DXCM) in Q1 2017, closing a stake of 323,748 shares — an estimated $4.83M sold.

IronBridge Capital Management first reported a position in DXCM in Q2 2014 and held it in 11 quarters. The position peaked at $19.2M in Q4 2014. 321 funds tracked by Wall St. Rank hold DXCM as of Q1 2017.

  • IronBridge Capital Management reported no remaining DexCom position as of Q1 2017 after selling out during the quarter.
  • IronBridge Capital Management sold 323,748 DexCom shares in Q1 2017, an estimated $4.83M.
  • IronBridge Capital Management first reported a position in DexCom in Q2 2014 and held it in 11 quarters.
  • IronBridge Capital Management's DexCom position peaked at $19.2M in Q4 2014.
  • 321 funds tracked by Wall St. Rank held DexCom as of Q1 2017.

Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.